Publicaciones en las que colabora con Vicente Mainar (32)

2023

  1. Spanish cardiac catheterization and coronary intervention registry. 32nd official report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990-2022)

    Revista Espanola de Cardiologia, Vol. 76, Núm. 12, pp. 1021-1031

2022

  1. Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial

    European Journal of Heart Failure, Vol. 24, Núm. 3, pp. 581-588

2021

  1. 10-Year Follow-Up of Patients With Everolimus-Eluting Versus Bare-Metal Stents After ST-Segment Elevation Myocardial Infarction

    Journal of the American College of Cardiology, Vol. 77, Núm. 9, pp. 1165-1178

  2. Outcomes of nonagenarians after transcatheter aortic valve implantation

    REC: Interventional Cardiology, Vol. 3, Núm. 4, pp. 250-257

  3. Pronóstico de pacientes nonagenarios tras implante percutáneo de válvula aórtica

    REC: Interventional Cardiology, Vol. 3, Núm. 4, pp. 250-257

2019

  1. Does Large Vessel Size Justify Use of Bare-Metal Stents in Primary Percutaneous Coronary Intervention?: Insights from the EXAMINATION Trial

    Circulation: Cardiovascular Interventions, Vol. 12, Núm. 9

  2. Long-term impact of diabetes in patients with ST-segment elevation myocardial infarction: Insights from the EXAMINATION randomized trial

    Catheterization and Cardiovascular Interventions, Vol. 94, Núm. 7, pp. 917-925

2018

  1. 3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents

    JACC: Cardiovascular Interventions, Vol. 11, Núm. 10, pp. 981-991

  2. Correlates of non-target vessel-related adverse events in patients with ST-segment elevation myocardial infarction: Insights from five-year follow-up of the EXAMINATION trial

    EuroIntervention, Vol. 13, Núm. 16, pp. 1939-1945

  3. Cost-effectiveness of everolimus-eluting versus bare-metal stents in ST-segment elevation myocardial infarction: An analysis from the EXAMINATION randomized controlled trial

    PLoS ONE, Vol. 13, Núm. 8

  4. Role of ST-Segment Resolution in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention (from the 5-Year Outcomes of the EXAMINATION [Evaluation of the Xience-V Stent in Acute Myocardial Infarction] Trial)

    American Journal of Cardiology, Vol. 121, Núm. 9, pp. 1039-1045

2017

  1. Impact of Body Mass Index on 5-Year Clinical Outcomes in Patients With ST–Segment Elevation Myocardial Infarction After Everolimus-Eluting or Bare-Metal Stent Implantation

    American Journal of Cardiology, Vol. 120, Núm. 9, pp. 1460-1466

  2. Impact of stent overlapping on long-term clinical outcomes in patients with ST-segment elevation myocardial infarction: Insights from the five-year follow-up of the EXAMINATION trial

    EuroIntervention, Vol. 13, Núm. 5, pp. e557-e563

2016

  1. A randomized comparison of novel bioresorbable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with acute coronary syndromes: The CENTURY II high risk ACS substudy

    Cardiovascular Revascularization Medicine, Vol. 17, Núm. 6, pp. 355-361

  2. Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trial

    The Lancet, Vol. 387, Núm. 10016, pp. 357-366

  3. Puncture Versus Surgical Cutdown Complications of Transfemoral Aortic Valve Implantation (from the Spanish TAVI Registry)

    American Journal of Cardiology, Vol. 118, Núm. 4, pp. 578-584

2015

  1. A Prospective Randomized Trial of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients with In-Stent Restenosis of Drug-Eluting Stents the RIBS IV Randomized Clinical Trial

    Journal of the American College of Cardiology, Vol. 66, Núm. 1, pp. 23-33

  2. Dual antiplatelet therapy duration after coronary stenting in clinical practice: Results of an EAPCI survey

    EuroIntervention, Vol. 11, Núm. 1, pp. 68-74

  3. Erratum: A prospective randomized trial of drug-eluting balloons versus everolimus-eluting stents in patients with in-stent restenosis of drug-eluting stents: The RIBS IV randomized clinical trial (Journal of the American College of Cardiology (2015) 66 (23-33))

    Journal of the American College of Cardiology

  4. Everolimus-eluting stent versus bare-metal stent in elderly (≥ 75 years) versus non-elderly (< 75 years) patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Insights from the examination trial

    International Journal of Cardiology, Vol. 179, pp. 73-78